Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
HEC Pharm
Welcome,
Profile
Billing
Logout
16 Products
0 Diseases
16 Products
19 Trials
114 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
yimitasvir
(DAG181) / Dongguan HEC TaiGen Biopharma, HEC Pharm
larotinib
(Z650) / HEC Pharm
ningetinib
(CT053PTSA) / HEC Pharm
antaitavir hasophate
(HEC74647PA) / HEC Pharm
morphothiadine mesilate
(GLS4) / HEC Pharm
yifenidone
(HEC585) / HEC Pharm
yiqibuvir
(HEC110114) / HEC Pharm
HEC96719
/ HEC Pharm
clifutinib
(HEC73543) / HEC Pharm
mitizodone phosphate
(HEC113995 PA) / HEC Pharm
rongliflozin
(HEC44616) / HEC Pharm
HEC53856
/ HEC Pharm
HEC68498
/ HEC Pharm
HEC83518
/ HEC Pharm
freethiadine
/ HEC Pharm
litapiprant
(HEC46877) / HEC Pharm
14028 injection
(dulaglutide biosimilar) / HEC Pharm
HEC116094
/ HEC Pharm
HEC121120
/ HEC Pharm
HEC122505MsOH
/ HEC Pharm
HEC169096
/ HEC Pharm
HEC73077
/ HEC Pharm
HEC89736
/ HEC Pharm
RD12014
(liraglutide biosimilar) / HEC Pharm
RD15003
(insulin degludec biosimilar) / HEC Pharm
insulin glargine biosimilar
/ Lannett, HEC Pharm
